Skip to main content

Advertisement

Table 7 Secondary analysis of factors associated with pre-term delivery among delivering women

From: Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania

Variable Pre-term delivery§ Crude OR P-value Adjusted OR P-value
  N No. PTD (%) (95% CI)   (95% CI)  
Maternal age   
<20 years 97 21 (21.65) 2.22 (1.23, 4.01) 0.008 2.92 (1.12, 7.65) 0.029
≥20 years 334 37 (11.08) Reference   Reference  
Health facility   
Geita hospital 265 25 (9.43) Reference   Reference  
Katoro HC 166 33 (19.88) 2.38 (1.36, 4.18) 0.002 2.02 (0.65, 6.35) 0.227
Peripheral malaria   
Positive 128 19 (14.84) 1.18 (0.65, 2.13) 0.584 0.36 (0.11, 1.10) 0.073
Negative 303 39 (12.87) Reference   Reference  
Level of education   
None/Primary 360 53 (14.72) 2.28 (0.88, 5.92) 0.091 1.69 (0.45, 6.33) 0.439
Secondary/Higher 71 5 (7.04) Reference   Reference  
Placental malaria   
Positive 162 33 (20.37) 2.50 (1.42, 4.38) 0.001 4.67 (1.74, 12.58) 0.002
Negative 269 25 (9.25) Reference   Reference  
MIP by RDT
Positive 84 16 (19.05) 1.71 (0.91, 3.22) 0.097 2.13 (0.69, 6.59) 0.188
Negative 347 42 (12.10) Reference   Reference  
SP receipt   
<3 doses 405 55 (13.58) Reference   Reference  
≥3 doses 26 3 (11.54) 0.83 (0.24, 2.86) 0.768 0.55 (0.13, 2.33) 0.416
Last SP time lapse   
≤4 weeks 26 14 (53.85) 0.47 (0.21, 1.06) 0.069 0.38 (0.15, 0.97) 0.042
>4 weeks 238 170 (71.43) Reference   Reference  
  1. HC = health centre; RDT = rapid diagnostic test, MIP = malaria in pregnancy, PTD = pre-term delivery, § = Assessed by first day of last menstrual period or by New Ballard Score; Significant p-values are presented in bold.